NR4A1 and neoplasm: Basal-like/triple negative tumours show low expression or lack hormone receptors and HER2, and some patients/tumours express higher levels of proliferation-related genes and basal markers like keratins 5, 6, 14, 17 and epidermal growth factor receptor (EGFR).